INmune Bio (NASDAQ:INMB) Price Target Raised to $30.00
INmune Bio (NASDAQ:INMB – Get Free Report) had its price target hoisted by investment analysts at Maxim Group from $22.00 to $30.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Maxim Group’s price target points to a potential upside of 226.80% from the […]
INmune Bio (NASDAQ:INMB – Get Free Report) had its price target hoisted by investment analysts at Maxim Group from $22.00 to $30.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Maxim Group’s price target points to a potential upside of 226.80% from the […]
